PURPOSE: To investigate the interchangeability of mixed and central venous-arterial carbon dioxide differences and the relation between the central difference (pCO₂ gap) and cardiac index (CI). We also investigated the value of the pCO₂ gap in outcome prediction. METHODS: We performed a post hoc analysis of a well-defined population of 53 patients with severe sepsis or septic shock. Mixed and central venous pCO₂ were determined earlier at a 6 h interval (T = 0 to T = 4) during the first 24 h after intensive care unit (ICU) admittance. The population was divided into two groups based on pCO₂ gap (cut off value 0.8 kPa). RESULTS: The mixed pCO₂ difference underestimated the central pCO₂ difference by a mean bias of 0.03 ± 0.32 kPa (95 % limits of agreement: -0.62-0.58 kPa). We observed a weak relation between pCO₂ gap and CI. The in hospital mortality rate was 21 % (6/29) for the low gap group and 29 % (7/24) for the high gap group; the odds ratio was 1.6 (95 % CI 0.5-5.5), p = 0.53. At T = 4 the odds ratio was 5.3 (95 % CI 0.9-30.7); p = 0.08. CONCLUSIONS: From a practical perspective, the clinical utility of central venous pCO₂ values is of potential interest in determining the venous-arterial pCO₂ difference. The likelihood of a bad outcome seems to be enhanced when a high pCO₂ gap persists after 24 h of therapy.
PURPOSE: To investigate the interchangeability of mixed and central venous-arterial carbon dioxide differences and the relation between the central difference (pCO₂ gap) and cardiac index (CI). We also investigated the value of the pCO₂ gap in outcome prediction. METHODS: We performed a post hoc analysis of a well-defined population of 53 patients with severe sepsis or septic shock. Mixed and central venous pCO₂ were determined earlier at a 6 h interval (T = 0 to T = 4) during the first 24 h after intensive care unit (ICU) admittance. The population was divided into two groups based on pCO₂ gap (cut off value 0.8 kPa). RESULTS: The mixed pCO₂ difference underestimated the central pCO₂ difference by a mean bias of 0.03 ± 0.32 kPa (95 % limits of agreement: -0.62-0.58 kPa). We observed a weak relation between pCO₂ gap and CI. The in hospital mortality rate was 21 % (6/29) for the low gap group and 29 % (7/24) for the high gap group; the odds ratio was 1.6 (95 % CI 0.5-5.5), p = 0.53. At T = 4 the odds ratio was 5.3 (95 % CI 0.9-30.7); p = 0.08. CONCLUSIONS: From a practical perspective, the clinical utility of central venous pCO₂ values is of potential interest in determining the venous-arterial pCO₂ difference. The likelihood of a bad outcome seems to be enhanced when a high pCO₂ gap persists after 24 h of therapy.
Authors: Joseph Cuschieri; Emanuel P Rivers; Michael W Donnino; Marius Katilius; Gordon Jacobsen; H Bryant Nguyen; Nikolai Pamukov; H Mathilda Horst Journal: Intensive Care Med Date: 2005-04-01 Impact factor: 17.440
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Intensive Care Med Date: 2003-03-28 Impact factor: 17.440
Authors: Jacques Creteur; Daniel De Backer; Yasser Sakr; Marc Koch; Jean-Louis Vincent Journal: Intensive Care Med Date: 2006-02-17 Impact factor: 17.440
Authors: R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Guillermo Gutierrez; Pablo Comignani; Luis Huespe; F Javier Hurtado; Arnaldo Dubin; Vinayak Jha; Yanina Arzani; Silvio Lazzeri; Lombardo Sosa; Juan Riva; Wolf Kohn; Daniela Suarez; Gonzalo Lacuesta; Daniela Olmos; Carlos Mizdraji; Alejandra Ojeda Journal: Intensive Care Med Date: 2008-04-30 Impact factor: 17.440
Authors: Paul A van Beest; Jorrit J Hofstra; Marcus J Schultz; E C Boerma; Peter E Spronk; Michael A Kuiper Journal: Crit Care Date: 2008-03-04 Impact factor: 9.097
Authors: P Saludes; L Proença; G Gruartmoner; L Enseñat; A Pérez-Madrigal; C Espinal; J Mesquida Journal: J Clin Monit Comput Date: 2016-11-10 Impact factor: 2.502